Deerfield Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Deerfield Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,006,126	Closed	-$62.6M	–	441
2023 Q4	$62.6M	Sell	1,006,126 -153,000	-13%	-$3.8M	1.16%	25
2023 Q3	$25.7M	Buy	+1,159,126	New	+$24.3M	0.57%	38

Deerfield Management's RYZB Position: Q1 2024 in Review

Deerfield Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 1,006,126 shares — an estimated $62.6M sold.

Deerfield Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $62.6M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Deerfield Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Deerfield Management sold 1,006,126 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $62.6M.
Deerfield Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Deerfield Management's RayzeBio, Inc. Common Stock position peaked at $62.6M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.